Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease (Q71548570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

title

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

7

Gelfand EW

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Paterson RL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

Lack G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

Domenico JM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

Delespesse G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

Leung DY

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

Finkel TH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

European Journal of Immunology

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

1979-1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

Role of IgE in atopic dermatitis

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Potentiation of human immunoglobulin E synthesis by plasma immunoglobulin E binding factors from patients with the hyperimmunoglobulin E syndrome

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Affinity-purified soluble Fc epsilon RII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti‐CD21 antibodies

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Co-crosslinking Fc epsilon RII/CD23 and B cell surface immunoglobulin modulates B cell activation

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Molecular structure of human lymphocyte receptor for immunoglobulin E

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Alternative transcripts of the human CD23/Fc epsilon RII. A possible novel mechanism of generating a soluble isoform in the type-II cell surface receptor

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

CD21 is a ligand for CD23 and regulates IgE production

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

T cells expressing specific V beta elements regulate immunoglobulin E production and airways responsiveness in vivo

1 reference

https://api.crossref.org/works/10.1002/EJI.1830260902

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814234 AND SRC:MED&resulttype=core&format=json

19 October 2019

1 reference